Why to assess radiosensitivity before radiation therapy?

radiotherapy tolerance tests

SHORT VERSION

Knowing each patient’s radiosensitivity level before treatment initiation allows:

  • in the absence of risk, reassuring the patient about radiotherapy;
  • in the presence of a risk of hypersensitivity, adapting the treatment and follow-up to minimize the occurrence of late complications and to manage them early.

Knowingeach patient’s radiosensitivity level is important because it can help to:

  • reassure the patient before starting radiation therapy
  • guide physicians in choosing the most appropriate treatment plan
  • adapt the patient’s follow-up after radiotherapy

Knowing the patient’s radiosensitivity level before treatment initiation can help to choose:

  • the radiotherapy technique
  • the total dose to be delivered
  • the number of sessions
  • the volume to be treated

If there is a proven risk of late radiotherapy-induced complications, an alternative treatment may be proposed to the patient if it is as effective as radiotherapy.

These different therapeutic options are discussed during the multidisciplinary team meeting and then with the patient.

[Radiotherapy hair loss

Notez cet post

FIRST TESTS TO PREDICT A PATIENT’S RADIOSENSITIVITY

NovaGray develops and commercializes the first radiotherapy tolerance tests for patients treated for breast or prostate cancer.

Performed before the start of radiotherapy with a simple blood draw, the tests assess the patients’ individual radiosensitivity and determine their risk of developing late complications after radiotherapy.

WHY DO A RADIOSENSITIVITY TEST?

Knowing a patient’s individual radiosensitivity is important information that can help:

  • Reassure the patient in preparation for radiotherapy
  • Guide physicians in choosing the most appropriate treatment plan
  • Adapt patient follow-up after radiotherapy

Team NovaGray

NovaGray develops radiotherapy tolerance tests for breast and prostate cancer patients. NovaGray's mission is to help personalize cancer treatment by assessing each patient's individual sensitivity before starting radiotherapy. NovaGray technology has been validated by multi-center prospective clinical trials. NovaGray tests are recommended by the French Society of Radiation Oncology (SFRO).